Soma LA - Search Results

1

Lamin B1 deletion in myeloid neoplasms causes nuclear anomaly and altered hematopoietic stem cell function.

Reilly A, Philip Creamer J, Stewart S, Stolla MC, Wang Y, Du J, Wellington R, Busch S, Estey EH, Becker PS, Fang M, Keel SB, Abkowitz JL, Soma LA, Ma J, Duan Z, Doulatov S. Reilly A, et al. Among authors: soma la. Cell Stem Cell. 2022 Apr 7;29(4):577-592.e8. doi: 10.1016/j.stem.2022.02.010. Epub 2022 Mar 11. Cell Stem Cell. 2022. PMID: 35278369 Free PMC article.

2

Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia.

Cassaday RD, Zarling LC, Garcia KA, Sala-Torra O, Stevenson PA, Martino CH, Liu YJ, Fang M, Percival MM, Halpern AB, Becker PS, Oehler VG, Shustov AR, Cooper JP, Orozco JJ, Hendrie PC, Walter RB, Radich JP, Soma LA, Estey EH. Cassaday RD, et al. Among authors: soma la. Leuk Lymphoma. 2023 May;64(5):927-937. doi: 10.1080/10428194.2023.2189803. Epub 2023 Mar 20. Leuk Lymphoma. 2023. PMID: 36938892 Free PMC article. Clinical Trial.

3

CD33 expression on natural killer cells is a potential confounder for residual disease detection in acute myeloid leukemia by flow cytometry.

Eckel AM, Cherian S, Miller V, Soma L. Eckel AM, et al. Cytometry B Clin Cytom. 2020 Mar;98(2):174-178. doi: 10.1002/cyto.b.21846. Epub 2019 Oct 17. Cytometry B Clin Cytom. 2020. PMID: 31622025 Free article.

4

The impact of histological grade on outcomes in follicular lymphoma: An analysis of patients in the SEER database in the context of evolving disease classification and treatment.

Naik A, Gooley T, Loeb K, Soma L, Smith SD, Gopal A, Naresh KN. Naik A, et al. Br J Haematol. 2022 Dec;199(5):696-706. doi: 10.1111/bjh.18404. Epub 2022 Aug 16. Br J Haematol. 2022. PMID: 35973829 Free PMC article.

5

Apparent CD19 expression by natural killer cells: a potential confounder for minimal residual disease detection by flow cytometry in B lymphoblastic leukemia.

Soma L, Wu D, Chen X, Edlefsen K, Fromm JR, Wood B. Soma L, et al. Cytometry B Clin Cytom. 2015 Mar;88(2):145-7. doi: 10.1002/cyto.b.21179. Epub 2014 Aug 4. Cytometry B Clin Cytom. 2015. PMID: 25091590 Free article.

6

Apparent CD19 expression by natural killer cells: A potential confounder for minimal residual disease detection by flow cytometry in B lymphoblastic leukemia.

Soma L, Wu D, Chen X, Edlefsen K, Fromm JR, Wood B. Soma L, et al. Cytometry B Clin Cytom. 2014 Jul 21. doi: 10.1002/cytob.21179. Online ahead of print. Cytometry B Clin Cytom. 2014. PMID: 25046149 Free article.

7

CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients.

Turtle CJ, Hanafi LA, Berger C, Gooley TA, Cherian S, Hudecek M, Sommermeyer D, Melville K, Pender B, Budiarto TM, Robinson E, Steevens NN, Chaney C, Soma L, Chen X, Yeung C, Wood B, Li D, Cao J, Heimfeld S, Jensen MC, Riddell SR, Maloney DG. Turtle CJ, et al. Among authors: soma l. J Clin Invest. 2016 Jun 1;126(6):2123-38. doi: 10.1172/JCI85309. Epub 2016 Apr 25. J Clin Invest. 2016. PMID: 27111235 Free PMC article. Clinical Trial.

8

Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells.

Turtle CJ, Hanafi LA, Berger C, Hudecek M, Pender B, Robinson E, Hawkins R, Chaney C, Cherian S, Chen X, Soma L, Wood B, Li D, Heimfeld S, Riddell SR, Maloney DG. Turtle CJ, et al. Among authors: soma l. Sci Transl Med. 2016 Sep 7;8(355):355ra116. doi: 10.1126/scitranslmed.aaf8621. Sci Transl Med. 2016. PMID: 27605551 Free PMC article. Clinical Trial.

9

Clinicopathologic Findings in Patients With Initial Diagnosis of Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) in Colorectal Mucosa.

Soma LA, Smith SD, Reddy P, Edlefsen KL, Wu D, Cherian S, Chen X, Zhou Y, Reddi D, Fromm JR. Soma LA, et al. Am J Clin Pathol. 2022 Jan 6;157(1):23-32. doi: 10.1093/ajcp/aqab089. Am J Clin Pathol. 2022. PMID: 34463316

10

Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution Experience.

Cooper JP, Khajaviyan S, Smith SD, Maloney DG, Shustov AR, Warren EH, Soma LA, Lynch RC, Ujjani C, Till B, Halpern AB, Gopal AK, Deeg HJ, Scott BL, Shadman M. Cooper JP, et al. Among authors: soma la. Clin Lymphoma Myeloma Leuk. 2019 Jun;19(6):390-395. doi: 10.1016/j.clml.2019.03.003. Epub 2019 Mar 11. Clin Lymphoma Myeloma Leuk. 2019. PMID: 30948330

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page